Fingerprint
Dive into the research topics of 'SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically